| Stage | CBT | % of rev | WDFC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $982M | 100.00% | $177M | 100.00% | CBT ×5.55 |
| Gross profit | $184M | 18.74% | $93M | 52.78% | WDFC +34.0pp |
| Operating income | $98M | 9.98% | $19M | 10.78% | WDFC +0.8pp |
| Pre-tax income | $58M | 5.91% | $18M | 10.45% | WDFC +4.5pp |
| Net income | $14M | 1.43% | $14M | 8.12% | WDFC +6.7pp |
| Stage | CBT | WDFC | Gap · A − B |
|---|---|---|---|
| Revenue | $982M100.00% | $177M100.00% | CBT ×5.55 |
| Gross profit | 18.74%$184M | 52.78%$93M | WDFC +34.0pp |
| Operating income | 9.98%$98M | 10.78%$19M | WDFC +0.8pp |
| Pre-tax income | 5.91%$58M | 10.45%$18M | WDFC +4.5pp |
| Net income |
| 1.43%$14M |
| 8.12%$14M |
| WDFC +6.7pp |